The lean body mass to visceral fat mass ratio is negatively associated with cardiometabolic disorders: a cross-sectional study
Open Access
- 27 January 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Abstract
The literature has documented conflicting and inconsistent associations between muscle-to-fat ratios and metabolic diseases. Additionally, different adipose tissues can have contrasting effects, with visceral adipose tissue being identified as particularly harmful. This study aimed to explore the relationship between the ratio of the lean mass index (LMI) to the visceral fat mass index (VFMI) and cardiometabolic disorders, including dyslipidemia, hypertension, and diabetes, as previous research on this topic is lacking. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in the United States and included 10,867 individuals. Logistic regression was employed to explore the association between LMI/VFMI and cardiometabolic disorders. Generalized additive models were utilized to examine the nonlinear relationships between variables. Data analysis revealed a consistent inverse association between ln(LMI/VFMI) and dyslipidemia, hypertension, and diabetes. Each 2.7-fold increase in LMI/VFMI (one unit of ln[LMI/VFMI]) was associated with lower odds ratios (ORs) for these conditions. In men, the ORs were 0.21 (95% CI 0.17–0.25) for dyslipidemia, 0.37 (95% CI 0.30–0.45) for hypertension, and 0.16 (95% CI 0.10–0.23) for diabetes. Similarly, in women, the ORs were 0.22 (95% CI 0.19–0.26), 0.51 (95% CI 0.42–0.61), and 0.19 (95% CI 0.13–0.27). Quartile analysis showed that participants in the highest quartile (Q4) had significantly lower ORs compared to those in the lowest quartile (Q1). In men, Q4 ORs were 0.18 (95% CI 0.14–0.23) for dyslipidemia, 0.30 (95% CI 0.23–0.39) for hypertension, and 0.11 (95% CI 0.06–0.20) for diabetes. In women, Q4 ORs were 0.12 (95% CI 0.10–0.15), 0.39 (95% CI 0.29–0.52), and 0.12 (95% CI 0.06–0.25), respectively. Dyslipidemia and diabetes demonstrated nonlinear patterns, while a linear association was found for hypertension. Subgroup analyses across various characteristics confirmed these findings with no substantial directional changes. Maintaining an appropriate ratio of LMI to VFMI may be associated with favorable metabolic health.Keywords
This publication has 63 references indexed in Scilit:
- Obesity Management in AdultsJAMA, 2023
- Changes in predicted lean body mass, appendicular skeletal muscle mass, and body fat mass and cardiovascular diseaseJournal of Cachexia, Sarcopenia and Muscle, 2022
- Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesityJournal of Cachexia, Sarcopenia and Muscle, 2021
- Increased odds of having the metabolic syndrome with greater fat‐free mass: counterintuitive results from the National Health and Nutrition Examination Survey databaseJournal of Cachexia, Sarcopenia and Muscle, 2021
- Fat‐to‐muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adultsJournal of Cachexia, Sarcopenia and Muscle, 2020
- A counterintuitive perspective for the role of fat‐free mass in metabolic healthJournal of Cachexia, Sarcopenia and Muscle, 2020
- Body Composition and Cardiovascular Events in Patients With Colorectal CancerJAMA Oncology, 2019
- Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery CalcificationJAMA Cardiology, 2019
- Association of Cardiometabolic Multimorbidity With MortalityJAMA, 2015
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001